Testing whether heart nerve signals predict COPD symptoms
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study looks at “sympathetic nerve activity” (signals from the nervous system that affect the heart) in adults with chronic obstructive pulmonary disease (COPD). The goal is to see whether these measurements can help predict what happens to people with COPD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able and willing to sign informed consent.
- You should not have atrial fibrillation (an irregular heartbeat).
- You should not have a pacemaker that actively sets your heartbeat (no “pacing” as the main rhythm).
- You should not have known major heart problems, such as significant high blood pressure or heart failure.
- You must not have been an inpatient (stayed overnight in the hospital) within the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a noninvasive device that stimulates a nerve in the face during exercise on a stationary bike. It aims to see if the device is feasible and safe for healthy adults and people with COPD.
This study measures how well the right side of your heart works when you are resting and when you exercise, in people with chronic obstructive pulmonary disease (COPD). It may help researchers better understand COPD-related heart strain and guide future care.
This study uses breath analysis and heart/electrical heart testing to look at how stiff the arteries are in people with long-term lung conditions. It may help researchers better understand lung disease effects on the cardiovascular system.
This study compares simple breathing tests (oscillometry and FeNO) used by your primary care doctor against a specialist's diagnosis to see if they can accurately tell if you have asthma or COPD. If you have symptoms like wheezing, cough, or shortness of breath but haven't been diagnosed yet, this trial may help improve how these conditions are found.
This study looks for undiagnosed COPD in people with heart conditions like coronary heart disease, atrial fibrillation, or chronic heart failure. If you have heart disease and are over 40, you may join to see if you also have COPD and benefit from combined care.
This study looks at how COPD affects your breathing and heart health. It is for people who are newly diagnosed with COPD and have a history of smoking.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.